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Monobenzyl Ether of Hydroquinone and 4-Tertiary
Butyl Phenol Activate Markedly Different
Physiological Responses in Melanocytes: Relevance to
Skin Depigmentation
Vidhya Hariharan1,2, Jared Klarquist1,2, Mary J. Reust1,2, Amy Koshoffer3, Mark D. McKee4,
Raymond E. Boissy3 and I. Caroline Le Poole1,2
Monobenzyl ether of hydroquinone (MBEH) is a Food and Drug Administration approved drug used for
depigmentation therapy of advanced vitiligo. Here, the working mechanism of MBEH is explored in comparison
to 4-tertiary butyl phenol (4-TBP), a known causative agent for occupational vitiligo mediating apoptotic
melanocytic death. Cytotoxic experiments reveal that similar to 4-TBP, MBEH induces specific melanocyte death.
To compare death pathways initiated by 4-TBP and MBEH, classical apoptotic hallmarks were evaluated in
treated melanocytes. MBEH induced cell death without activating the caspase cascade or DNA fragmentation,
showing that the death pathway is non-apoptotic. Release of High Mobility Group Box-1 protein by MBEH-
treated melanocytes and ultrastructural features further confirmed a necrotic death pathway mediated by
MBEH. A negative correlation between MBEH-induced cell death and cellular melanin content supports a
cytoprotective role for melanin. Moreover, MBEH exposure upregulated the levels of melanogenic enzymes in
cultured melanocytes and skin explants, whereas 4-TBP reduced the expression of the same. In summary,
exposure to MBEH or 4-TBP has profoundly different consequences for melanocyte physiology and activates
different death pathways. As the mode of cell death defines the nature of the immune response that follows,
these findings help to explain the relative efficacy of these agents in mediating depigmentation.
Journal of Investigative Dermatology (2010) 130, 211–220; doi:10.1038/jid.2009.214; published online 6 August 2009
INTRODUCTION
Vitiligo, a chronic pigmentary disorder, results from a T-cell
mediated autoimmune response toward melanocytes (Le
Poole and Luiten, 2008). Patients with advanced vitiligo
can opt to biochemically remove remaining pigmentation
(Lim and Camile, 2007). For depigmentation therapy, new
methods are gradually becoming available including the use
of 4-methoxy phenol combined with Q-switched ruby laser
or cryotherapy (Lotti et al., 2008). However, monobenzyl
ether of hydroquinone (MBEH) remains the only drug that the
Food and Drug Administration approved for depigmentation
therapy within the United States (Bolognia et al., 2001). The
working mechanism of MBEH remains unexplored, although
MBEH is believed to remove melanocytes from the skin, as it
generally mediates permanent depigmentation (Bolognia
et al., 2001). However, in some patients, repigmentation
has been observed after treatment (Oakley, 1996).
The depigmentation process that follows exposure to
phenolic agent 4-tertiary butyl phenol (4-TBP) is better
understood. Occupational vitiligo in some individuals work-
ing in the rubber and tannery industries has been attributed to
4-TBP (Boissy and Manga, 2004). In vitro studies have shown
that 4-TBP is specifically cytotoxic to melanocytes. Though
4-TBP is a tyrosine analog that binds the catalytic site of the
tyrosinase enzyme and acts as a competitive inhibitor of
tyrosinase (Yang and Boissy, 1999), the cytotoxic effects were
found to be independent of tyrosinase activity (Yang and
Boissy, 1999; Yang et al., 2000). The latter studies revealed
that sensitivity of melanocytes to 4-TBP instead correlates
with the level of tyrosinase-related protein 1 (TRP-1)
expressed by melanocytes (Manga et al., 2006). Normal
melanocytes were shown to downregulate the levels of
microphthalmia-associated transcription factor and TRP-1 in
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response to 4-TBP as a protective mechanism (Manga et al.,
2006). Finally, 4-TBP is shown to activate apoptosis in
melanocytes (Yang et al., 2000).
The two main categories of cell death are apoptosis and
necrosis. Apoptosis is a well defined and programmed cell
death with classical hallmarks such as membrane blebbing,
nuclear fragmentation, activation of the caspase cascade, and
changes in mitochondrial permeability (Krysko et al., 2008).
As an early signal, cells undergoing apoptosis display surface
expression of phosphatidyl serine and are opsonized for
phagocytosis by phosphatidyl serine receptor expressing
macrophages (Fadok et al., 1992, 1998). Alternatively,
necrosis is an unregulated form of cell death characterized
by cytoplasmic swelling, and disintegration of the
plasma membrane and cellular organelles (Krysko
et al., 2008). Necrotic cells stimulate an inflammatory
response by releasing immune stimulatory agents like
DNA-binding High Mobility Group Box-1 protein (HMGB1),
heat shock proteins, DNA and RNA (Scaffidi et al.,
2002; Krysko et al., 2006), and necrosis is therefore
considered a strong inducer of immune responses (Krysko
et al., 2006).
The current study is focused on understanding whether
MBEH intersects with the melanogenic pathway and med-
iates selective cytotoxicity to melanocytes by in vitro
cytotoxicity assays using melanocytes, fibroblasts, and
keratinocytes isolated from human skin. The appearance of
apoptotic hallmarks in response to chemical exposure was
assessed by FACS analysis of surface phosphatidyl serine
expression as an early apoptotic marker. Activation of the
caspase cascade was assessed by western blotting and
fluorimetric assays to identify products of caspase-3 and poly
(ADP-ribose) polymerase (PARP) cleavage. Possible alterna-
tive modes of cell death were followed by electron
microscopic comparison of cultured cells exposed to 4-TBP
or MBEH followed by analysis of HMGB1 release in
supernatants of treated cells. Studies were expanded to
include a model more closely mimicking human skin; DNA
fragmentation was analyzed by TUNEL staining of organo-
typic skin cultures. Further, the potential involvement of
melanogenic enzymes in depigmentation was assessed by
correlating sensitivity to MBEH with basal expression levels
of melanogenic enzymes and melanin content among
melanocyte monocultures measured by FACS analysis and
a standard quantitative melanin assay. Changes in the
expression levels of melanosomal markers on treatment with
4-TBP or MBEH were identified by FACS analysis of cultured
cells, and confirmed by immunohistochemistry of cultured
skin explants. Besides a further understanding of the
consequences of topical exposure to bleaching agents per
se, the current investigations shed light on the potential of
these agents to achieve complete and permanent depigmen-
tation of the skin in vitiligo patients.
RESULTS
Cytotoxicity quantification
The viability of cultured human primary melanocytes,
fibroblasts, and keratinocytes was determined through MTT
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) assays after treating with 250, 500, and 900mM of
4-TBP or MBEH for 24 hours. In Figure 1, data are shown for a
representative of two experiments performed. Vehicle treat-
ment served as a control for all cell types. In Figure 1a, the
viability of melanocytes was reduced by 26 and 67% in
response with 250 and 500 mM of 4-TBP, respectively. Upon
250 and 500mM concentrations of MBEH treatment, the
viability of melanocytes was reduced by 43 and 77%,
respectively, as shown in Figure 1b, indicating an increased
potency of MBEH in comparison with 4-TBP. Surprisingly,
fibroblasts and melanocytes were equally sensitive to both
treatments, yet keratinocytes were significantly more resistant
to both 250 or 500 mM concentrations. The viability of
keratinocytes remained unchanged upon 250 mM exposure,
whereas at 500 mM the viability was reduced only by 21 and
31% on 4-TBP and MBEH treatment, respectively. Thus, both
bleaching phenols are selectively cytotoxic to melanocytes
among epidermal cells. Finally, at the highest concentration,
viability was not observed in any cell type for either
treatment.
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Figure 1. Cytotoxicity of monobenzyl ether of hydroquinone (MBEH) and
4-tertiary butyl phenol (4-TBP) toward cutaneous cells. Epidermal foreskin-
derived melanocytes Mf0814 P5, Mf0932 P2, Mf0883 P3, and Mf0929 P3
with respective melanin contents of 55.0, 10.7, 8.1, and 28.4 pg per cell,
fibroblasts (Ff0201 P4) and keratinocytes (Kf0180 P14) were treated with 250,
500 and 900 mM of 4-TBP (a) or MBEH (b) for 24 hours. The percent viability
was calculated through MTT assays. Mean and SD were calculated and
statistical significance was evaluated by Student’s t-test. *Po0.05 and
**Po0.01 for melanocyte viability in comparison with keratinocytes
after 250 and 500mM treatment of 4-TBP and MBEH treatment.
212 Journal of Investigative Dermatology (2010), Volume 130
V Hariharan et al.
MBEH Induces Melanocyte Necrosis
Analysis of annexin-V staining
Melanocytes treated with 4-TBP or MBEH (500 or 900 mM for
1 hour) were stained with FITC-labeled antibody to annexin-V
along with propidium iodide. Propidium iodide-positive cells
were gated out and the percentage of apoptosis was
estimated in live cells. At 900 mM of 4-TBP, melanocytes
revealed a substantial apoptotic population (18.4%) as shown
in Figure 2. As melanocytes are more sensitive to MBEH than
to 4-TBP as shown in Figure 1, data are included for 1-hour
treatment with both 900 and 500mM of MBEH to ensure that
apoptosis is not induced at a lower concentration of the drug.
Figure 2 further confirms that no apoptosis was observed on
treatment with MBEH. Cells treated with vehicle alone served
as controls for both treatments.
Caspase-3 and PARP detection
Cleavage of caspase-3 is a critical indicator of the apoptotic
cascade. To quantify the enzymatic activity of caspase-3, cell
extracts pre-treated with either agent for 1 hour were
incubated with a synthetic caspase-3 peptide substrate that
emits fluorescence on cleavage. In a representative experi-
ment shown in Figure 3a, MBEH treatment did not impact the
level of caspase-3 activity in comparison with vehicle
treatment at either concentration used. However, melano-
cytes treated with 4-TBP significantly increased caspase-3
activity in response to the 900mM concentration (Po0.05).
Western blot analysis shown in Figure 3b further confirmed
that MBEH treatment did not induce caspase-3 cleavage,
whereas 4-TBP treatment induced cleavage of pro-caspase
into active caspase. Cleavage of PARP, a downstream target
of caspase-3, was similarly evaluated by western blotting. As
expected, PARP cleavage was observed in response to
treatment with 900 mM of 4-TBP, but not following MBEH
treatment (Figure 3c).
Analysis of necrotic changes
Ultrastructural changes in response to 4-TBP and MBEH
exposure were examined by electron microscopy. Physiolo-
gical changes in treated cells were most readily demonstrable
at the 1mM concentration for 1 hour, as shown in represen-
tative images of individual cells in Figure 4a. An electron
micrograph of intact cells is shown for vehicle treatment
alone. Exposure to 4-TBP produced defined apoptotic
features including formation of apoptotic bodies, cytoplasmic
vaculorization, blebbing of the plasma membrane, and a
condensed nucleus while maintaining plasma membrane
integrity. MBEH-treated cells revealed typical necrotic
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Figure 2. Annexin-V staining of monobenzyl ether of hydroquinone (MBEH)- and 4-tertiary butyl phenol (4-TBP)-treated cells.Melanocytes were treated with
500 or 900mM of 4-TBP or MBEH (solid line) or vehicle alone (gray line) for 1 hour. FACS analysis of annexin-V staining, gating out PI-stained (dead) cells,
showed that 4-TBP but not MBEH-induced apoptotic cell death.
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Figure 3. Caspase-3 and poly (ADP-ribose) polymerase (PARP) in MBEH and
4-TBP-treated cells.Melanocytes were treated with 500 or 900mM of 4-TBP or
MBEH for 1 hour and analyzed for (a) caspase-3 activity, (b) cleavage of
caspase-3, and (c) PARP cleavage. (a) Caspase-3 activity (nanomoles per
milligram per hour) was quantified based on the amount of fluorescence
emitted on cleavage of the substrate Ac-DEVD-AFC. Statistical significance at
*Po0.05 was observed for caspase-3 activity after 900 mM treatment of 4-TBP
over vehicle treatment. (b) Cleavage of caspase-3 identified through western
blotting revealed no caspase-3 cleavage after MBEH treatment, whereas
4-TBP treatment does induce cleavage of pro-caspase (32 kD) into active
caspase (11 kD). (c) Treatment with 4-TBP treatment induced cleavage of
PARP (116 kD) into inactive PARP (89 kD), whereas MBEH treatment did not
induce PARP cleavage. GAPDH, glyceraldehyde 3-phosphate
dehydrogenase.
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features such as disruption of the plasma membrane and
release of cellular contents. Even at 125-mM treatment for
4 hours, similar ultrastructural features could be observed in
response to MBEH, but not to 4-TBP (not shown). Moreover,
the release of HMGB1 in the supernatants of melanocytes
treated with 900mM of 4-TBP or MBEH for 1 hour was
analyzed through western blotting. As expected, HMGB1
was released on MBEH treatment alone, further confirming
the necrotic pathway (Figure 4b).
Confocal analysis of DNA fragmentation in exposed skin
DNA fragmentation in treated explants was analyzed by
TUNEL staining. Human skin explants of 6mm in diameter
were treated with 5 ml of 250mM of 4-TBP or MBEH for 1 day.
Control explants were treated with vehicle alone. Cryosec-
tions were immunostained with antigen-presenting cell-
labeled anti-MART-1 (melanoma antigen recognized by
T cells-1), incorporating FITC-labeled nucleotides with the
Klenow fragment of DNA polymerase to free ends
of fragmented DNA. Sections were counterstained with 40,
6-diamidino-2-phenylindole to identify cell nuclei. Stained
sections were analyzed by confocal microscopy (Figure 5).
Similar to control samples, MBEH-treated explants showed
focal DNA fragmentation in the granular layer of the
epidermis and in the dermis, whereas no apoptotic signal
was observed throughout the basal layer where melanocytes
are situated. Apoptotic melanocytes were observed in 4-TBP-
treated skin with colocalization of TUNEL (in green) and
MART-1 staining (red). 4-TBP treatment induced DNA
fragmentation in 80% of basal melanocytes within skin
explants as opposed to MBEH treatment where not a single
apoptotic melanocyte was observed. Note that at the high
concentration of either agent used, keratinocyte apoptosis
was observed within 4-TBP-treated explants only, further
emphasizing the contrast between both agents.
Role of pigmentation in MBEH-mediated death
A role for melanin in the toxicity induced by MBEH was
identified by correlating melanocyte viability after MBEH
exposure to melanin levels observed in cultured melanocytes.
In Figure 6a, a positive correlation between cellular melanin
content and viability after MBEH treatment was observed,
with a correlation coefficient of 0.6. By contrast, melanin
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Figure 4. Analysis of necrotic changes. (a) Morphological changes in
melanocytes treated with 1mM 4-tertiary butyl phenol (4-TBP) or monobenzyl
ether of hydroquinone (MBEH) or vehicle alone for 1 hour were evaluated by
electron microscopy. Vehicle-treated cells show intact plasma membranes
(arrows) and nuclear membranes (asterisks). 4-TBP treatment induced
apoptotic changes, including cytoplasmic vacuolarization (filled arrowheads),
plasma membrane blebbing (open arrow heads), and formation of apoptotic
bodies (carrot symbol). MBEH treatment induced necrotic changes consisting
of plasma membrane (arrows) and cytoplasmic disintegration. Bars¼2 mm.
(b) Western blot analysis of melanocyte (Mf0930 P2) supernatant to detect
High Mobility Group Box-1 protein (HMGB1) after treatment with 900mM
of 4-TBP or MBEH for 1 hour. Release of HMGB1 was identified after
MBEH treatment alone. Serum albumin bands observed in the respective
supernatants were shown to demonstrate equal loading.
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content did not correlate with cell death mediated by 4-TBP.
In Figure 6b, expression levels of melanogenic enzymes
tyrosinase, TRP-1, and TRP-2 was shown for six melanocyte
cultures arranged from left to right according to increasing
viability in presence of MBEH. Indeed, sensitivity to MBEH
was not specifically associated with the levels of expression
of any of these melanogenic enzymes. Interestingly, whereas
the expression levels of tyrosinase and TRP-1 vary with
melanin content, no such association was shown for TRP-2,
suggesting that TRP-2 expression is of less importance for
melanization. Taken together, the data support a protective
role of melanin in MBEH-induced cell death.
Melanosomal marker analysis through intracellular staining
Relative changes in the expression of melanosomal proteins
were identified in melanocytes pre-treated with 4-TBP or
MBEH versus treatment with vehicle alone. As shown
in Figure 7, 4-TBP-treated melanocytes expressed levels of
TRP-1, tyrosinase and, TRP-2 reduced by 37, 20, and 23%,
respectively. MBEH-treated melanocytes displayed an oppo-
site trend with the levels of TRP-1, tyrosinase, and TRP-2
increased by 13, 67, and 81% over vehicle-treated cells,
respectively.
Melanosomal marker analysis in ex vivo organotypic cultures
Changes in the expression of melanosomal marker proteins
were further followed in an ex vivo environment through
organotypic culture of human skin treated daily with 5 ml of
4-TBP or MBEH. Analysis of immunostained sections con-
firmed observations reported for FACS analysis of cultured
cells described above. After 24 hours, treatment with 250mM
of 4-TBP markedly downregulated the expression of gp100,
TRP-1, tyrosinase, MART-1, and TRP-2, whereas slightly
increased expression of the same markers was observed after
Vehicle 4-TBP MBEH
Figure 5. DNA fragmentation within monobenzyl ether of hydroquinone (MBEH)- or 4-tertiary butyl phenol (4-TBP)-treated skin. Apoptosis was shown in
confocal microscopic images of explant cultures exposed to 5ml of 250mM 4-TBP or MBEH for 24 hours. Vehicle treatment alone served as control. Melanocytes
immunostained with antibodies to MART-1 were shown in red and DNA fragmentation was represented in green. Nuclear counterstaining by DAPI was
observed in blue. Colocalization of all three colors is visible in white. Vehicle- and MBEH-treated skin sections lacked DNA fragmentation in the basal epithelial
layer, whereas 4-TBP treatment showed melanocytes expressing DNA fragmentation. Bar¼ 20 mm.
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Figure 6. Role of pigmentation in monobenzyl ether of hydroquinone
(MBEH)-mediated death. (a) Melanocytes were treated with 500mM of
4-tertiary butyl phenol (4-TBP) or MBEH for 24 hours and cell viability
was quantified through MTT assays. Melanocyte viability was correlated
with baseline cellular melanin content. (b) The baseline expression
levels of TRP-1, tyrosinase, and TRP-2 were quantified by FACS analysis.
Expression levels of melanogenic enzymes reported for individual
melanocyte cultures were arranged according to increasing melanocyte
viability on MBEH exposure from left to right. The melanin content of
each melanocyte culture was reported in picogram per cell underneath
the culture name.
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MBEH treatment (Figure 8). It should also be noted that 4-TBP
treatment downregulated the levels of anti-apoptotic factor
Bcl-2, whereas no appreciable change was observed in
response to MBEH. Images shown are from a representative
of three experiments performed.
DISCUSSION
MBEH (10–20%) is used in dermatology clinics within the
United States for depigmentation treatment of patients with
advanced vitiligo (Bolognia et al., 2001). The current studies
report on the underlying mechanism by which MBEH
mediates human skin depigmentation, which, to our knowl-
edge, has not previously been reported. Viability assays
showed that similar to 4-TBP, MBEH induces specific toxicity
toward melanocytes, as previously suggested by studies in
mice (Quevedo et al., 1990; Yang and Boissy, 1999). At the
same time, fibroblast and melanocytes are equally sensitive
to both the agents, suggesting that neither agent should be
used for systemic administration, thus limiting their use to
topical applications. Previous studies have reported that the
mechanism of melanocyte destruction by 4-TBP is through
apoptosis (Yang et al., 2000). MBEH-induced cell death was
therefore expected to follow a similar death pathway.
Surprisingly, MBEH treatment of cultured melanocytes
induced unique morphological changes when compared
with 4-TBP treatment. Although 4-TBP treatment induced
perinuclear vacuolarization and membrane ruffling, MBEH
treatment induced disintegration of cellular membrane and
release of cellular contents as observed by light microscopy
(data not shown). This suggested that the mechanism of death
initiated by MBEH may be different from that observed in
response to 4-TBP. Further studies confirmed that MBEH-
induced cytotoxicity lacked classical apoptotic hallmarks
such as caspase-3 activity, cleavage of caspase-3 or PARP
proteins, exposure of phosphatidyl serine, and DNA frag-
mentation. Further, a downregulation of Bcl-2 expression in
the basal epidermal layer of treated explant cultures was
observed on 4-TBP treatment, but not in response to MBEH.
Electron micrographs confirmed the presence of necrotic
changes including disruption of the plasma membrane and
the nuclear membrane. Furthermore, release of HMGB1 was
observed after MBEH treatment alone, further emphasizing
the same fact. Previous studies have shown that active PARP
is required for the release of HMGB1 (Ditsworth et al., 2007) .
This explains the lack of HMGB1 release on 4-TBP treatment,
as 4-TBP induces cleavage and inactivation of PARP.
During programmed apoptotic cell death, inflammation is
a rare event, although macrophage influx is required for a
rapid clearance of apoptotic cells (Chung et al., 2000; Krysko
et al., 2006). If apoptotic cells are not phagocytized
immediately, dying cells are cleared through a necrosis-like
mechanism referred to as secondary necrosis. Though
secondary necrosis is characterized by certain necrosis-like
changes, nuclear fragmentation and chromatin condensation
are also observed (Silva et al., 2008). MBEH-mediated
cytotoxicity does not induce regulated nuclear fragmentation
as seen by TUNEL staining, thus ruling out secondary necrosis
as the mechanism of cell death. Taking into account the
structural, morphological, and biochemical changes ob-
served, it was clearly shown that MBEH induces necrotic
death in human melanocytes.
Correlative studies between melanin content and mela-
nocyte sensitivity on MBEH exposure indicate that melanin
acts as a protective agent against MBEH-induced cell death.
This implies that people with a darker complexion may
benefit less from MBEH depigmentation treatment. This is
countered by the fact that recent studies implicate tyrosinase
as the enzyme mediating depigmentation in response to
MBEH (Westerhof and d’Ischia 2007; van den Boorn et al.,
2008). In this regard, MBEH seems to be converted into a
quinone product on interaction with tyrosinase (van den
Boorn et al., 2008). The accumulation of such quinone
products may induce toxicity selectively in melanocytes
(Riley, 1970). Alternatively, the possibility should be con-
sidered that MBEH preferentially enters melanocytes as
previously shown for 4-hydroxy anisole in melanocyte–ker-
atinocyte co-cultures (Riley, 1970). In either case the
melanosome likely hosts the depigmenting compound, as
further supported by the protective effect of melanin against
MBEH-induced cell death.
The upregulation of melanosomal markers through in-
tracellular and immunohistochemistry on MBEH treatment
may in part explain the repigmentation observed in some
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Figure 7. Melanosomal marker analysis in cultured melanocytes.
Melanocytes (Mf0639 P6) were treated with 250 mM of 4-TBP or monobenzyl
ether of hydroquinone (MBEH) for 72 hours. The cells were stained for
expression of TRP-1, TRP-2 and tyrosinase, and the expression levels were
quantified by FACS analysis. (a) Histogram showing representative FACS
staining for tyrosinase and (b) bar graph indicating relative expression levels of
tyrosinase-related protein-1 (TRP-1), tyrosinase (TYR), and tyrosinase-related
protein-2 (TRP-2) compared with vehicle-treated cells.
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patients after depigmentation therapy (Bolognia et al., 2001),
although a repopulation of depigmented skin by melanocytes
is likely required for such repigmentation to occur. Therefore,
it is postulated that a balance exists between the protective
effects of melanin and the toxic effects of quinone accumula-
tion. Cell death occurs if quinone accumulation prevails.
This explains the lack of a direct association between the
sensitivity to MBEH and the basal levels of tyrosinase, TRP-1,
or TRP-2, as the presence of melanin overshadows the toxic
effects of quinone products generated on interaction with
increasing levels of melanosomal enzymes. This observation
contrasts with the observed decrease in TRP-1 levels
associated with increased viability on 4-TBP exposure
(Manga et al., 2006). Overall, chemical exposure was
accompanied by opposing consequences for the expression
of melanosomal enzymes both in vitro and ex vitro. In
conclusion, different mechanisms are involved in chemical
depigmentation of the skin by 4-TBP and MBEH. This leaves
 VehicleMBEH 4-TBP
Tyrosinase
TRP-2
TRP-1
gp100
MART-1
Bcl-2
Figure 8. Melanosomal marker analysis in ex vivo organotypic cultures. Explant skin cultures were treated with 250mM of 4-tertiary butyl phenol (4-TBP) or
monobenzyl ether of hydroquinone (MBEH) for 24 hours. Vehicle treatments alone served as controls. The vertical columns represent respective treatments and
the immunohistochemistry images representing expression levels of tyrosinase, TRP-2, TRP-1, gp100, MART-1, and Bcl-2 are shown in horizontal columns.
Sections representing 4-TBP treatment revealed markedly downregulated levels of melanosomal markers as well as of Bcl-2, whereas MBEH treatment slightly
upregulated the levels of expression of all markers studied by melanocytes in the basal layer of the epidermis. Bar¼ 75 mm.
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the intriguing question why one agent induces apoptosis and
the other necrosis of the same target cells. The explanation
may in part be found in the different side chains to either
phenolic agent and in the resulting differences in molecular
structure potentially imposing differential reactivity towards
melanocytes.
Both 4-TBP and MBEH are specifically cytotoxic to
melanocytes on topical application with vastly different
physiological consequences, favoring the application of
MBEH in a treatment setting. The data imply that MBEH is
more likely to invoke an inflammatory response and induce
autoreactivity to melanosomal antigens, which may explain
distant depigmentation away from the application site
observed for this compound (Bolognia et al., 2001) It may
be possible to identify previously unreported molecular
derivatives or combinatory treatments providing more rapid
depigmentation of the skin. The current studies provide
an incentive for studies to unravel the possible impact of
either agent on immunological responses to dying melano-
cytes, which can impact on the permanent features of
depigmentation.
MATERIALS AND METHODS
Cell culture
Cultures of normal human melanocytes, keratinocytes, and fibro-
blasts were established from otherwise discarded foreskin tissue
obtained after routine circumcision. All studies performed with
human tissue were carried out in adherence with the Declaration of
Helsinki Principles and were approved by the Institutional Review
Board of the institution where circumcisions were performed. Patient
consent was not necessary. Dermo-epidermal separation was
performed by incubation with 0.5mgml1 thermolysin (Sigma,
St Louis, MO). Epithelial cells were further separated by incubation
in 0.1% trypsin. Cells or dermal tissue were plated in keratinocyte,
melanocyte, or fibroblast growth media.
Normal human melanocytes were cultured in Ham’s F-12
medium (Media-Tech, Herndon, VA) with 2mM Glutamine
(Invitrogen, Carlsbad, CA), 100 IUml1 penicillin, 100 mgml1
streptomycin, 100mgml1 amphotericin (Invitrogen), 0.1mM
isobutylmethylxanthine (Sigma), 10 ngml1 12-O-tetradecanoyl-
phorbol-13-acetate (Sigma), and 1% Ultroser G (Pall Biosepra,
Cergy, France).
Normal human dermal fibroblasts were cultured in DMEM
(Media-Tech) with 10% heat-inactivated fetal bovine serum (Gemini
Bio-products, West Sacramento, CA), 100 IUml1 penicillin,
100mgml1 streptomycin, and 100mgml1 amphotericin (Media-Tech).
Normal human keratinocytes were cultured in growth medium
with M154 basal medium (Cascade Biologicals, Portland, OR),
supplemented with human keratinocyte growth supplements (Cas-
cade Biologicals) with 100 IUml1 penicillin, 100mgml1 strepto-
mycin, 100mgml1 amphotericin (Invitrogen), and immortalized
with HPV16 E6 and E7 retroviral constructs as described previously
to allow prolonged passaging (Halbert et al., 1991).
Organotypic culture
Organotypic culture was performed as described previously (Le Poole
et al., 1994) . In brief, 6-mm biopsies were punched from other-
wise discarded foreskin tissue obtained after routine circumcision
from University of Chicago. The explants were cultured in DMEM
containing 10% inactivated normal human serum at the air–liquid
interphase in 0.4mm transwell plates with epidermal side facing up
(Corning, Teterboro, NJ). After treatment with 5 ml of 250mM of
4-TBP or MBEH for 24 hours, explants were embedded in optimal
cutting temperature compound (OCT) (Sakura Finetek USA, Tor-
rance, CA) and snap frozen for future sectioning. All studies
performed with human tissue were carried out in adherence with
the Declaration of Helsinki Principles and were approved by the
Institutional Review Board of the institution where circumcisions
were performed.
Cytotoxicity assay
Cell viability was measured by MTT assays (Bioassay system,
Hayward, CA) according to manufacturer’s instructions. In brief,
20,000 cells per well were plated in triplicate wells of a 96-well
plate to attach overnight. Cells were either treated with vehicle alone
or with 250 or 500 mM of 4-TBP or MBEH for 24 hours. 4-TBP (Sigma)
was prepared as a stock solution of 250mM in 70% ethanol. MBEH
(Sigma) was dissolved in 20% dimethyl sulfoxide and mixed with
70% ethanol for a stock concentration of 250mM. The use of a
vehicle control refers to the use of 20% dimethyl sulfoxide in 70%
ethanol. MTT reagent (tetrazole) was added to the cells and
incubated in a 371C humidified chamber for 4 hours. Tetrazole is
converted to formazan in the mitochondria of living cells. The
formazan crystals formed were dissolved in solubilization buffer and
the absorbance was read in a spectrophotometer at a wavelength of
562 nm (BMG Labtech, Durham, NC). Cell viability was calculated
as a percentage of absorbance of the samples relative to untreated
control.
Apoptosis assay: flow cytometry
Cells were stained using an annexin-V-FITC Apoptosis Detection Kit
(Invitrogen) according to the manufacturer’s instructions. Briefly,
equal numbers of melanocytes (Mf0639 P4) were plated and treated
with 500 or 900 mM of 4-TBP or MBEH for 1 hour. Floating and
adherent cells were combined and subsequently incubated for
15minutes with annexin-V-FITC and propidium iodide. Cells were
acquired with a FACScanto (Becton Dickinson, SanJose, CA) and
analyzed with Flowjo software (TreeStar, Ashland, OR). Cells in the
FITC-positive and propidium iodide-negative fraction were quanti-
fied as apoptotic cells.
Fluorogenic substrate assay
Caspase-3 activity was quantified using a fluorogenic substrate
(Chaturvedi et al., 2006). Briefly, equal amounts of cultured
melanocytes (Mf0861, P4) were treated with 500 or 900mM of 4-
TBP or MBEH for 1 hour. Cells were then lysed in 50 ml of lysis buffer
(25mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid),
10% sucrose, 0.1% 3-[(3-cholamidopropyl)dimethylamino]-1
propane sulfonate, and 2mM EDTA) and protein concentrations
were determined by Bradford assays. Equal amount of protein was
mixed with assay buffer (25mM HEPES, 5mM dithiothreitol, and
100mM of substrate Ac(N-acetyl)-DVED-AFC (7-amino-4-trifluro-
methylcoumarin) and the reaction was incubated at 37 1C for
2.5 hours. Fluorescence was determined as a measure of caspase-3
activity in a cytofluor multi-well plate reader with 360 nm as
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excitation and 530nm as emission wavelengths (Invitrogen).
The enzyme activity was reported as nmoles per milligram of
protein per hour.
Western blots
To investigate the expression level of pro-apoptotic factors,
melanocytes cells were treated with 500 or 900mM of 4-TBP or
MBEH for 1 hour. Vehicle-treated cells served as control. Cells were
washed in phosphate-buffered saline and incubated in lysis buffer
(50 nM Tris, 2mM EDTA, 150mM NaCl, and 1% Triton-X-100) in
presence of a protease inhibitor cocktail (Roche, Indianapolis, IN).
Cell extracts were spun, and protein content was estimated in the
supernatant according to manufactures’ instruction using Bio-Rad
protein assay reagent (Bio-Rad, Hercules, CA). Cellular proteins
were electrophoresed in a 10% polyacrylamide gel and were
transferred to a PVDF membrane (Millipore, Billerica, MA). The blots
were incubated with a rabbit polyclonal anti-caspase-3 antibody
(Santa Cruz Biotechnology, Santa Cruz, CA), a rabbit polyclonal
anti-PARP antibody (Santa Cruz Biotechnology), or a mouse
monoclonal anti-HMGB1 antibody (Novus biologicals, Littleton,
CO), as well as with monoclonal anti-GAPDH (glyceral-
dehyde 3-phosphate dehydrogenase) (Chemicon, Temecula, CA).
Biotinylated anti-mouse IgG (Dako, Carpinteria, CA) or anti-rabbit
IgG (Santa Cruz Biotechnology) antibodies were added followed
by peroxidase-labeled streptavidin (Dako). Peroxidase activity
was detected by ECL chemiluminesence in a film imager
(Fuji, Stamford, CT).
Electron microscopy
For ultrastructural studies, melanocytes were seeded in multi-well
Lab-Tek chamber slides (Nunc, Naperville, IL). Adherent cells were
processed for electron microscopy as previously described
(Boissy et al., 1991). Briefly, cells were fixed in wells with
half-strength Karnovsky’s fixative in 0.2 M sodium cacodylate buffer
at pH 7.2 for 30minutes at room temperature. Cells were then
treated with 1% osmium tetroxide containing 1.5% potassium
ferrocyanide for 30minutes and stained en bloc with 0.5% uranyl
acetate for 30minutes, dehydrated, and embedded in Eponate 12.
Three areas of each culture were cut out of the Epon cast, mounted
on Epon pegs, and sectioned on an RMC MT 6000-XL ultra-
microtome. Ultra thin sections were then stained with aqueous
solutions of uranyl acetate (2%) and lead citrate (0.3%)
for 15minutes each, and viewed and digitally photographed
using a JEOL JEM-1230 transmission electron microscope (JEOL,
Peabody, MA). Tissue-processing supplies were purchased from Ted
Pella (Tustin, CA).
TUNEL assay
Biopsies (6mm) obtained from skin tissue were cultured and treated
as described under the organotypic culture heading. Unfixed 8-mm
cryosections were initially incubated with primary antibody M2-9E3
to MART-1 (Covance, Dedham, MA). Sections were then fixed in 1%
paraformaldehyde and stained for DNA fragmentation using an
ApopTag Fluorescein In situ Apoptosis Detection Kit (Chemicon)
according to the manufacturer’s instructions. In brief, sections were
incubated with dioxygenin-labeled oligonucleotides in presence of
TdT (terminal deoxynucleotidyl transferase) enzyme to extend the
30OH breaks of the DNA. FITC-labeled nucleotides were added,
followed by phycoerythrin-labeled streptavidin (Dako). The sections
were analyzed by confocal analysis with a Zeiss LSM-510
microscope (Zeiss, Thornwood, NY) after counterstaining with
40, 6-diamidino-2-phenylindole (Invitrogen). The microscope offers
different lasers used to detect the individual fluorochromes included
in this assay. 40, 6-diamidino-2-phenylindole fluorescence was
identified using a Diode laser exciting at 405 nm. Phycoerythrin
was monitored using a HeNE 633 laser. Detection of FITC was
performed using a multiline-argon laser exciting at 488 nm.
Intracellular staining
Melanocytes treated with 250mM of 4-TBP or MBEH for 72 hours
were lifted with 0.5mM EDTA. For permeabilization, cells were fixed
in 2% paraformaldehyde, and washed with 0.03% saponin. The cells
were incubated for 1 hour at 4 1C with monoclonal antibody Ta99 to
TRP-1 (Covance), goat polyclonal antibody D-18 to TRP-2 (Santa
Cruz Biotechnology), monoclonal antibody T311 to tyrosinase
(Neomarkers, Fremont, MA) prepared in 0.3% saponin. Biotinylated
anti-mouse IgG (Dako) or anti-goat IgG (Santa Cruz Biotechnology)
were used as secondary antisera followed by phycoerythrin-labeled
streptavidin (Dako). Flourescence data were acquired with a BD
FACScanto flow cytometer (Becton Dickinson) and analyzed with
Flowjo software (TreeStar).
Immunohistochemistry
Treated organotypic skin cultures were obtained as described above.
Cryosections of 8-mm thickness were stained with monoclonal
antibody Ta99 to TRP-1, goat polyclonal antibody D-18 to TRP-2,
monoclonal antibody T311 to tyrosinase, monoclonal antibody
M29-E3 to MART-1, monoclonal antibody NKI-Beteb to gp-100, or
monoclonal 124 to Bcl-2 (Dako). Biotinylated anti-mouse (Dako) or
anti-goat (Santa Cruz Biotechnology) were used in the second step
followed with peroxidase-labeled streptavidin (Dako). Images were
captured by an Olympus BX41 bright field microscope (Olympus,
Center Valley, PA).
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